Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea

CompletedOBSERVATIONAL

Enrollment

756

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

bimatoprost/timolol

Bimatoprost/timolol (Ganfort®) treatment for open-angle glaucoma or ocular hypertension as per local standard of care in clinical practice.

Trial Locations (1)

Seoul